Infectious Diseases News and Research

RSS

PaxVax partners with UC to develop combination vaccine to prevent genital HSV infections

PaxVax Inc., a specialty vaccine company with a commercial focus on travel and biodefense and a social mission to ensure global access to its vaccines, today announced that it has entered into a research and development collaboration with the University of California, San Diego to develop a combination vaccine to prevent genital herpes simplex virus (HSV) infections.

10 Jun 2014

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity and clinical responses of its immunotherapy product, INO-3112, in treating human papillomavirus (HPV)- associated head and neck cancer.

10 Jun 2014

Synthetic, Enterome partner to study effects of beta-lactam antibiotics on gastrointestinal microflora

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients.

10 Jun 2014

Wistar findings suggest means of boosting initial immune response

Your first response to an infectious agent or antigen ordinarily takes about a week, and is relatively weak. However, if your immune system encounters that antigen a second time, the so-called memory response is rapid, powerful, and very effective.

10 Jun 2014

Research on viral RNA may help scientists develop treatments against infectious diseases

In an article published in the scientific journal Nature, a University of Colorado School of Medicine researcher and colleagues explain how RNA molecules found in certain viruses mimic the shape of other molecules as part of a strategy to 'hijack' the cell and make more viruses.

10 Jun 2014

MERS virus can be transmitted from camel to man

A report published yesterday provided the first solid evidence that the Middle East Respiratory Syndrome (MERS) virus (MERS-cov) can be contracted by man through close contact with an infected camel.

9 Jun 2014

S. pneumoniae is major cause of severe pneumonia in Gambian children

Researchers have published a detailed survey of children with pneumonia in the Gambia, which reveals that Streptococcus pneumoniae is the predominant aetiological agent and that multiple pathogens are present in at least half of cases.

9 Jun 2014

Anthrax, brucellosis and bovine TB fail to receive official recognition, say researchers

Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.

9 Jun 2014

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences International, Inc. received approval of the New Drug Application (NDA) for BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA).

9 Jun 2014

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).

9 Jun 2014

Bacteria exposure may help protect babies from wheezing and allergic disease

Research funded by the National Institutes of Health suggests that exposure to specific combinations of allergens and bacteria within the first year of life may protect children from wheezing and allergic disease.

9 Jun 2014

Research finding could lead to new strategies for malaria control

Researchers have found the first evidence of an intercellular bacterial infection in natural populations of two species of Anopheles mosquitoes, the major vectors of malaria in Africa. The infection, called Wolbachia, has been shown in labs to reduce the incidence of pathogen infections in mosquitoes and has the potential to be used in controlling malaria-transmitting mosquito populations.

6 Jun 2014

U.S. Preventive Services Task Force recommends hepatitis B screening for high risk individuals

A simple blood test can detect if a person is one of the two billion people worldwide infected with hepatitis B. And now the U.S. Preventive Services Task Force recommends that all teens and adults who are high risk for hepatitis B get screened for the infection.

6 Jun 2014

Tech Collective invites applications and nominations for 2014 Rhode Island Bioscience Awards

Tech Collective, Rhode Island's Bioscience and Information Technology industry association, today announces the launch of its 2014 Rhode Island Bioscience Awards.

6 Jun 2014

Newborns exposed to rodent, pet dander and household bacteria less likely to have allergy, asthma

Infants exposed to rodent and pet dander, roach allergens and a wide variety of household bacteria in the first year of life appear less likely to suffer from allergies, wheezing and asthma, according to results of a study conducted by scientists at the Johns Hopkins Children's Center and other institutions.

6 Jun 2014

New TB blood test could eliminate unnecessary treatment

A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives.

6 Jun 2014

Device used in physics and chemistry reveals dynamics of pervasive pathogen

If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of-big, both proportionately and epidemiologically.

6 Jun 2014

Canadian invasive pneumococcal disease outbreak characterised

Canadian scientists have reported details of an outbreak of serotype 12F invasive pneumococcal disease that occurred in Winnipeg between 2009 and 2011 and predominantly affected people who were homeless and/or engaged in illegal drug use.

5 Jun 2014

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.

5 Jun 2014

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

In the battle against stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), a new single-dose antibiotic is as effective as a twice-daily infusion given for up to 10 days, according to a large study led by Duke Medicine researchers.

5 Jun 2014

Infectious Diseases News and Research

PaxVax partners with UC to develop combination vaccine to prevent genital HSV infections

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Synthetic, Enterome partner to study effects of beta-lactam antibiotics on gastrointestinal microflora

Wistar findings suggest means of boosting initial immune response

Research on viral RNA may help scientists develop treatments against infectious diseases

MERS virus can be transmitted from camel to man

S. pneumoniae is major cause of severe pneumonia in Gambian children

Anthrax, brucellosis and bovine TB fail to receive official recognition, say researchers

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Bacteria exposure may help protect babies from wheezing and allergic disease

Research finding could lead to new strategies for malaria control

U.S. Preventive Services Task Force recommends hepatitis B screening for high risk individuals

Tech Collective invites applications and nominations for 2014 Rhode Island Bioscience Awards

Newborns exposed to rodent, pet dander and household bacteria less likely to have allergy, asthma

New TB blood test could eliminate unnecessary treatment

Device used in physics and chemistry reveals dynamics of pervasive pathogen

Canadian invasive pneumococcal disease outbreak characterised

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

NGS for Infectious Disease Surveillance eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News